K-numberK233956
Device nameAulisa Infant Oximeter Module (2nd Gen.) (GA-OM0018)
ApplicantTaiwan Aulisa Medical Devices Technologies, Inc.
Product codeDQA
Device classClass II
Decision dateJan 30, 2025
DecisionSubstantially Equivalent
Regulation870.2700
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Aulisa Infant Oximeter Module (2nd Gen.) is a wireless, foot-worn sensor that continuously measures and displays pulse rate and oxygen saturation (SpO2) in infant patients. It transmits data via Bluetooth to a mobile device running Aulisa software for display and review, and is intended for spot-checking or continuous monitoring in hospitals, medical facilities, home care, and subacute environments during non-motion and well-perfused conditions.

Technological characteristics

The subject device uses red (660 nm) and infrared (905 nm) LED technology, achieving SpO2 accuracy of ±3 digits (70–100%) and pulse rate accuracy of ±3 digits (30–290 bpm). It connects directly to an AC charger via USB Type-C, whereas predicate devices used a charging case. Both subject and primary predicate use Bluetooth only; the secondary predicate adds Wi-Fi. All three measure at the foot and are reusable.

Test standards cited

ISO 80601-2-61 (pulse oximeter performance), IEC 60601-1 and IEC 60601-1-11 (electrical safety and home use), IEC 60601-1-2 (EMC), ISO 10993-5/10/23 (biocompatibility), ANSI C63.27 (wireless coexistence), and FDA guidance on pulse oximeters, software V&V, cybersecurity, human factors, and clinical testing.

Substantial equivalence argument

The subject device has identical indications for use, measurement parameters (SpO2 and pulse rate), measurement sites (foot), use environments, and technology (red/infrared LEDs with Bluetooth transmission) as the predicate devices. Minor differences—such as the 905 nm versus 880 nm infrared wavelength, stricter pulse rate accuracy range (30–290 bpm vs. 30–300 bpm), and direct USB Type-C charging instead of a charging case—do not affect safety or effectiveness. Clinical testing confirmed SpO2 ARMS <3 digits over 70–100%, meeting manufacturer specifications and predicate performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →